---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-059526"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-05-20T20:10:53+00:00"
generated_at: "2026-05-20T21:36:31.414074+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 20/20 BioLabs Q1 revenue $0.4M, net loss $2.2M; expects Q2 rebound from firefighter programs

## Summary
- Q1 revenue $0.4M vs $0.6M YoY; net loss $2.2M vs $0.8M; gross margin 17.8% vs 29.9%.
- Cash $4.2M (vs $1.0M Dec 2025) after $5M private placement; deferred revenue $0.5M.
- State-funded firefighter cancer screening programs expected to drive meaningful Q2 revenue; second state committed.
- Launched OneTest for Longevity with IBM; exclusive U.S. CKD license from ROKIT Healthcare.
- Medicare MCED Screening Act signed Feb 2026; pathway for Medicare coverage by 2028.

## SEC filing metadata
- accession: 0001213900-26-059526
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-05-20T20:10:53+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/0001213900-26-059526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/ea0291642-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-059526
- JSON: https://secwatch.observer/filing/0001213900-26-059526.json
- Plain text: https://secwatch.observer/filing/0001213900-26-059526.txt

## Key facts
- Earnings Releases
  20/20 Biolabs, Inc. reported the first quarter ended March 31, 2026 results: revenue $0.4 million.
  - Period: the first quarter ended March 31, 2026
  - Revenue: $0.4 million
  - Result: reported results
  source text: Total revenue for the three months ended March 31, 2026 was $0.4 million, compared to $0.6 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/0001213900-26-059526-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.